Non-Pharmacological Segment by Treatment Type Is Expected to Grow at A Fast Pace Over the Forecast Period
According to a new market research study of 'Atrial Fibrillation Market to 2027 - Global Analysis and Forecasts by Treatment Type and End User.' The global atrial fibrillation market is expected to reach US$ 18,085.96 Mn in 2027 from US$ 6,446.08 Mn in 2019. The market is estimated to grow with a CAGR of 14.0% from 2020-2027. The report provides trends prevailing in the global Atrial Fibrillation Market and the factors driving market along with those that act as hindrances.
The global Atrial Fibrillation Market, based on the treatment type, is segmented into non-pharmacological, and pharmacological. The end user segment is segmented into hospitals, ambulatory surgical centers, and cardiac catheterization laboratories. In 2019, the non-pharmacological accounted for the largest market share in the global atrial fibrillation market by treatment type owing to common use of surgical devices for the treatment of cardiac arrhythmias. Moreover, medications to treat atrial fibrillation are not always successful and hence non-pharmacological techniques are widely adopted. Thus, owing to these benefits and their wide acceptance of non-pharmacological techniques the non-pharmacological held the largest share in the market.
The market for x-ray photoelectron spectroscopy is expected to grow, owing to factors such as increasing prevalence of atrial fibrillation and rising awareness regarding atrial fibrillation are expected to boost the market growth over the years. Moreover, growth opportunities in the developing nations are likely to have a positive impact on the growth of the market in coming years.
Leading companies operating in the atrial fibrillation market are Boston Scientific Corporation, Medtronic, AtriCure, Inc, Biosense Webster, Inc., BOEHRINGER INGELHEIM GMBH, CardioFocus, Abbott, Sanofi, Biotronik, Inc., and Bristol-Myers Squibb Company among others.
The report segments Global Atrial Fibrillation Market as follows:
Global Atrial Fibrillation Market - By Treatment Type
Global Atrial Fibrillation Market - By End User
Global Atrial Fibrillation Market - By Geography
Reasons to Buy:
According to a new market research study of 'Atrial Fibrillation Market to 2027 - Global Analysis and Forecasts by Treatment Type and End User.' The global atrial fibrillation market is expected to reach US$ 18,085.96 Mn in 2027 from US$ 6,446.08 Mn in 2019. The market is estimated to grow with a CAGR of 14.0% from 2020-2027. The report provides trends prevailing in the global Atrial Fibrillation Market and the factors driving market along with those that act as hindrances.
The global Atrial Fibrillation Market, based on the treatment type, is segmented into non-pharmacological, and pharmacological. The end user segment is segmented into hospitals, ambulatory surgical centers, and cardiac catheterization laboratories. In 2019, the non-pharmacological accounted for the largest market share in the global atrial fibrillation market by treatment type owing to common use of surgical devices for the treatment of cardiac arrhythmias. Moreover, medications to treat atrial fibrillation are not always successful and hence non-pharmacological techniques are widely adopted. Thus, owing to these benefits and their wide acceptance of non-pharmacological techniques the non-pharmacological held the largest share in the market.
The market for x-ray photoelectron spectroscopy is expected to grow, owing to factors such as increasing prevalence of atrial fibrillation and rising awareness regarding atrial fibrillation are expected to boost the market growth over the years. Moreover, growth opportunities in the developing nations are likely to have a positive impact on the growth of the market in coming years.
Leading companies operating in the atrial fibrillation market are Boston Scientific Corporation, Medtronic, AtriCure, Inc, Biosense Webster, Inc., BOEHRINGER INGELHEIM GMBH, CardioFocus, Abbott, Sanofi, Biotronik, Inc., and Bristol-Myers Squibb Company among others.
The report segments Global Atrial Fibrillation Market as follows:
Global Atrial Fibrillation Market - By Treatment Type
- Non - pharmacological
- MAZE Surgery
- Catheter Ablation
- Electric Cardioversion
- Pharmacological
- Anti-arrhythmic Drugs
- Anti-coagulant Drugs
Global Atrial Fibrillation Market - By End User
- Hospitals
- Ambulatory Surgical Centers,
- Cardiac Catheterization Laboratories
Global Atrial Fibrillation Market - By Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- U.K
- Spain
- Italy
- Asia Pacific (APAC)
- China
- India
- Japan
- Australia
- South Korea
- Middle East & Africa (MEA)
- Saudi Arabia
- U.A.E
- South Africa
- South & Central America (SCAM)
- Brazil
- Argentina
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the atrial fibrillation market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global atrial fibrillation market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction
3. Research Methodology
4. Atrial Fibrillation- Market Landscape
5. Atrial Fibrillation Market - Key Dynamics
6. Atrial Fibrillation Market - Global Analysis
7. Atrial Fibrillation Market Analysis and Forecast - By Treatment Type
8. Atrial Fibrillation Market Analysis and Forecast to 2027 - End-User
9. Atrial Fibrillation Market - Geographic Analysis
10. Atrial Fibrillation Market -Industry Landscape
11. Atrial Fibrillation Market- Key Company Profiles
12. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Boston Scientific Corporation
- Medtronic
- AtriCure, Inc
- Biosense Webster, Inc.
- BOEHRINGER INGELHEIM GMBH
- CardioFocus
- Abbott
- Sanofi
- Biotronik Inc.
- Bristol-Myers Squibb Company
